Sam Eldessouky - 01 Jun 2021 Form 4 Insider Report for Bausch Health Companies Inc. (BHC)

Reporting owner
Role
EVP & Chief Financial Officer
Signature
/s/ Kirsten O'Donnell, attorney-in-fact for Sam Eldessouky
Issuer context
Issuer symbol
BHC
Transaction snapshot
Transactions as of
01 Jun 2021
Net transaction value
+$3,921,337
SEC evidence
Form type
4
Filing time
03 Jun 2021, 17:26:21 UTC
Next filing
15 Jun 2021
SEC filing
View on sec.gov

Key filing fact

Sam Eldessouky filed Form 4 for Bausch Health Companies Inc. (BHC) on 03 Jun 2021.

Key facts

  • This page summarizes Sam Eldessouky's Form 4 filing for Bausch Health Companies Inc. (BHC).
  • 2 reported transactions and 1 derivative row are listed below.
  • Filing timestamp: 03 Jun 2021, 17:26.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: +$3,921,337.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reported transactions

BHC transaction

Common Shares, No Par Value

Award

Transaction value
$0
Shares
+33,673
Change %
+34%
Price
$0.000000
Shares after
133,857
Date
01 Jun 2021
Ownership
Direct
Footnotes
F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

BHC transaction Derivative

Non-Qualified Stock Options (right to purchase)

Award

Transaction value
$3,921,337
Shares
+122,427
Change %
Price
$32.03
Shares after
122,427
Date
01 Jun 2021
Ownership
Direct
Underlying class
Common Shares, No Par Value
Underlying amount
122,427
Exercise price
$32.03
Footnotes
F2
* indicates a reported price that failed the local validity check.

Explanation of Responses:

Id Content
F1 Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of the Issuer
F2 The options vest in equal installments on each of the first three anniversaries of the date of grant.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .